tiprankstipranks
Tenax Therapeutics (TENX)
NASDAQ:TENX
US Market

Tenax Therapeutics (TENX) Financial Statements

480 Followers

Tenax Therapeutics Financial Overview

Tenax Therapeutics's market cap is currently ―. The company's EPS TTM is $-24.542; its P/E ratio is -0.14; Tenax Therapeutics is scheduled to report earnings on August 19, 2024, and the estimated EPS forecast is $-1.99. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -4.03M$ -1.97M$ -1.10M$ -1.40M$ -2.54M
EBITDA$ -4.03M$ -1.97M$ -1.10M$ -1.40M$ -2.51M
Net Income Common Stockholders$ 3.80M$ -1.97M$ -1.11M$ -1.41M$ -2.55M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 13.39M$ 14.41M$ 2.12M
Total Assets$ 14.46M$ 11.89M$ 14.05M$ 15.27M$ 3.40M
Total Debt$ 413.17K$ 174.47K$ 345.75K$ 513.91K$ 688.50K
Net Debt$ 413.17K$ 174.47K$ -13.05M$ -13.90M$ -1.44M
Total Liabilities$ 2.03M$ 602.21K$ 823.84K$ 993.86K$ 1.91M
Stockholders Equity$ 12.43M$ 11.29M$ 13.22M$ 14.28M$ 1.49M
Cash Flow-
Free Cash Flow$ 2.43M$ -2.08M$ -924.57K$ -1.73M$ -2.31M
Operating Cash Flow$ 2.43M$ -2.08M$ -922.97K$ -1.72M$ -2.31M
Investing Cash Flow--$ 1.60K$ 1.24K$ 4.00K
Financing Cash Flow$ 7.92M$ -171.28K$ -99.91K$ 14.01M$ 626.37K
Currency in USD

Tenax Therapeutics Earnings and Revenue History

Tenax Therapeutics Debt to Assets

Tenax Therapeutics Cash Flow

Tenax Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis